Nontransplantation of livers from deceased donors who are able to donate another solid organ: How often and why it happens

American Journal of Transplantation

Volumn 7, Issue 1, 2007, Pages 151-160

  Sayuk, G S ^a   Leet, T L ^b   Schnitzler, M A ^b   Hayashi, P H ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Saint Louis University   (United States)

Author keywords

Donation; Procurement; Transplantation; Utilization

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN;

ADOLESCENT; ADULT; AGE; AGED; AGING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; COVARIANCE; FEMALE; HEART DEATH; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SEROLOGY; TIME SERIES ANALYSIS;

ADULT; AGE FACTORS; CADAVER; CASE-CONTROL STUDIES; CAUSE OF DEATH; DEATH; ENZYME TESTS; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OBESITY; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 33845650914     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01600.x     Document Type: Article

References (22)

1. Ojo AO, Heinrichs D, Emond JC et al. Organ donation and utilization in the USA. Am J Transplant 2004; 4(Suppl 9): 27-37.
2. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651-663.
3. Ploeg RJ, D'Alessandro AM, Knechtle SJ et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55: 807-813.
4. Workgroup on expanded criteria organs for liver transplantation. Liver Transpl 2005; 11: 1184-1192.
5. Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
6. Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 2004; 8: 501-519, vii.
7. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
8. Trends in aging - United States and worldwide. MMWR Morb Mortal Wkly Rep 2003;52: 101-104, 106.
9. World Health Organization. Physical status: The use and interpretation of anthropometry, Geneva, Switzerland. World Health Organization Technical Report Series 1995.
10. Kimm SY, Obarzanek E. Childhood obesity: A new pandemic of the new millennium. Pediatrics 2002; 110: 1003-1007.
11. Kahen TSJ, Lavine J, Stanley C, Behling C. Population prevalence of pediatric fatty liver disease. Gastroenterology 2004; 126: A-753.
12. Afonso RC, Saad WA, Parra OM, Leitao R, Ferraz-Neto BH. Impact of steatotic grafts on initial function and prognosis after liver transplantation. Transplant Proc 2004; 36: 909-911.
13. Ploeg RJ, D'Alessandro AM, Hoffmann RM et al. Impact of donor factors and preservation on function and survival after liver transplantation. Transplant Proc 1993; 25: 3031-3033.
14. Briceno J, Marchal T, Padillo J, Solorzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation 2002; 74: 522-526.
15. Hoofnagle JH, Lombardero M, Zetterman RK et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24: 89-96.
16. Piratvisuth T, Tredger JM, Hayllar KA, Williams R. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg 1995; 1: 296-301.
17. Fernandez-Merino FJ, Nuno-Garza J, Lopez-Hervas P et al. Impact of donor, recipient, and graft features on the development of primary dysfunction in liver transplants. Transplant Proc 2003; 35: 1793-1794.
18. Tisone G, Manzia TM, Zazza S et al. Marginal donors in liver transplantation. Transplant Proc 2004; 36: 525-526.
19. Mor E, Klintmalm GB, Gonwa TA et al. The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation 1992; 53: 383-386.
20. Koepsell TD, Weiss NS. Epidemiological Methods. New York, NY: Oxford University Press, 2003: 206-208.
21. National Center for Health Statistics. CDC: Ten leading causes of death by age group, United States - 2001. http://www.chdl.org/Projects/ 10%20Leading%20Causes%20of%20Death %20by%20Age%20Group%202001.pdf. Accessed Aug 10, 2006.
22. Cameron A, Busuttil RW. AASLD/ILTS transplant course: Is there an extended donor suitable for everyone? Liver Transpl 2005; 11: S2-S5.